Terms: = Kidney tumors AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
329 results:
1. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
[TBL] [Abstract] [Full Text] [Related]
2. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
[TBL] [Abstract] [Full Text] [Related]
3. Incidence trends of kidney cancer in China from 1990 to 2019: A joinpoint and age-period-cohort analysis.
Zhang L; Li Y; Ren N; Zhu T; Zhang D; Ou S; Yin D
Clin Nephrol; 2024 Apr; 101(4):181-190. PubMed ID: 38214174
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
6. Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.
Borges Dos Reis R; Shu X; Ye Y; Borregales L; Karam JA; Adibi M; Wu X; Reis LO; Wood CG
Clin Genitourin Cancer; 2024 Feb; 22(1):e156-e162.e4. PubMed ID: 37945405
[TBL] [Abstract] [Full Text] [Related]
7. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract] [Full Text] [Related]
8. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
Huang HP; Chen CH; Chang KH; Lee MS; Lee CF; Chao YH; Lu SY; Wu TF; Liang ST; Lin CY; Lin YC; Liu SP; Lu YC; Shun CT; Huang WJ; Lin TP; Ku MH; Chung HJ; Chang YH; Liao CH; Yu CC; Chung SD; Tsai YC; Wu CC; Chen KC; Ho CH; Hsiao PW; Pu YS
J Transl Med; 2023 Oct; 21(1):714. PubMed ID: 37821919
[TBL] [Abstract] [Full Text] [Related]
10. The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study.
Andresen K; Carreira H; Strongman H; McDonald HI; Benitez-Majano S; Mansfield KE; Nitsch D; Tomlinson LA; Bhaskaran K
BMC Cancer; 2023 Sep; 23(1):839. PubMed ID: 37679679
[TBL] [Abstract] [Full Text] [Related]
11. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA UFC1 acts as an oncogene via stimulating EZH2-induced inhibition of apc expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski JM; Winter KA; Prestidge BR; Sanda MG; Amin M; Bice WS; Gay HA; Ibbott GS; Crook JM; Catton CN; Raben A; Bosch W; Beyer DC; Frank SJ; Papagikos MA; Rosenthal SA; Barthold HJ; Roach M; Moughan J; Sandler HM
J Clin Oncol; 2023 Aug; 41(24):4035-4044. PubMed ID: 37315297
[TBL] [Abstract] [Full Text] [Related]
14. The role of warm ischemia time on functional outcomes after robotic partial nephrectomy: a radionuclide renal scan study from the clock randomized trial.
Antonelli AD; Cindolo L; Sandri M; Veccia A; Annino F; Bertagna F; Di Maida F; Celia A; D'Orta C; De Concilio B; Furlan M; Giommoni V; Ingrosso M; Mari A; Nucciotti R; Olianti C; Porreca A; Primiceri G; Schips L; Sessa F; Bove P; Simeone C; Minervini A;
World J Urol; 2023 May; 41(5):1337-1344. PubMed ID: 37085644
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of the Mortality Trends of 23 Major Cancers in the Indian Population Between 2000 and 2019: A Joinpoint Regression Analysis.
Shaji A; Keechilat P; Dk V; Sauvaget C
JCO Glob Oncol; 2023 Mar; 9():e2200405. PubMed ID: 36947728
[TBL] [Abstract] [Full Text] [Related]
16. Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program.
Rebuzzi SE; Signori A; Buti S; Banna GL; Murianni V; Damassi A; Maruzzo M; Giannarelli D; Tortora G; Galli L; Rizzo M; De Giorgi U; Antonuzzo L; Bracarda S; Cartenì G; Atzori F; Tamberi S; Procopio G; Fratino L; Lo Re G; Santoni M; Baldessari C; Astone A; Calabrò F; Brunelli M; Porta C; Rescigno P; Basso U; Fornarini G
ESMO Open; 2022 Dec; 7(6):100634. PubMed ID: 36493602
[TBL] [Abstract] [Full Text] [Related]
17. WHO/ISUP grade and pathological T stage of clear cell renal cell carcinoma: value of ZOOMit diffusion kurtosis imaging and chemical exchange saturation transfer imaging.
Li S; He K; Yuan G; Yong X; Meng X; Feng C; Zhang Y; Kamel IR; Li Z
Eur Radiol; 2023 Jun; 33(6):4429-4439. PubMed ID: 36472697
[TBL] [Abstract] [Full Text] [Related]
18. Comparative analysis of surgical and oncologic outcomes of robotic, laparoscopic and open radical nephrectomy with venous thrombectomy: a propensity-matched cohort study.
Zhang Y; Bi H; Yan Y; Liu Z; Wang G; Song Y; Zhang S; Liu C; Ma L
Int J Clin Oncol; 2023 Jan; 28(1):145-154. PubMed ID: 36380158
[TBL] [Abstract] [Full Text] [Related]
19. Risk of skin cancer in kidney, liver and heart recipients: A nationwide population-based study in Taiwan.
Liu SW; Wang WM; Chiang CP; Chung CH; Tsao CH; Chien WC; Hung CT
Indian J Dermatol Venereol Leprol; 2023; 89(3):372-377. PubMed ID: 36331847
[TBL] [Abstract] [Full Text] [Related]
20. Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial.
Apolo AB; Powles T; Escudier B; Burotto M; Zhang J; Simsek B; Scheffold C; Motzer RJ; Choueiri TK
Eur J Cancer; 2022 Dec; 177():63-71. PubMed ID: 36327527
[TBL] [Abstract] [Full Text] [Related]
[Next]
